Detection of fragile sites induced by pyrimethamine

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 17, Issue 2, 1997, Pages 59-69

  Egeli, U ^a   Tunca, B ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Chromosomal aberrations; Fragile site; G banding; Lymphocyte culture; Pyrimethamine

Indexed keywords

PYRIMETHAMINE;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL;

ADULT; ANTIMALARIALS; CELL CULTURE TECHNIQUES; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; FEMALE; HUMANS; KARYOTYPING; LYMPHOCYTES; MALE; PYRIMETHAMINE;

EID: 0030811917     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1997)17:2<59::AID-TCM2>3.0.CO;2-D     Document Type: Article

References (38)

1. Glover WT, Stein CK: Chromosome breakage and recombination at fragile sites. Am J Hum Genet 43:265-273, 1988.
2. Fundai AF, Larippa IB: Coincidence in fragile site expression with fluorodeoxyuridine and bromodeoxyuridine. Cancer Genet Cytogenet 41:41-48, 1989.
3. Sutherland GR: Fragile sites on human chromosome: Demonstration of their dependence on the type of tissue culture medium. Science 197:265-266, 1977.
4. Sutherland GR: Heritable fragile sites on human chromosomes. II. Distribution, phenotypic effects and cytogenetics. Am J Hum Genet 31:136-148, 1979.
5. Harvey J, Judge C, Wiener S: Familial X-linked mental retardation with an X chromosome abnormality. J Med Genet 14:46-50, 1977.
6. Yunis JJ: The chromosomal basis of human neoplasia. Science 221:227-236, 1983.
7. Le Beau MM, Rowley JD: Heritable fragile sites in cancer. Nature 308:607-608, 1984.
8. Yunis JJ: Fragile sites and predisposition to leukemia and lymphoma. Cancer Genet Cytogenet 12:85-88, 1984.
9. De Brackeler M, Smith B, Lin CC: Fragile sites and structural rearrangements in cancer. Hum Genet 69:112-116, 1985.
10. Le Beau MM: Chromosomal fragile sites and cancer specific rearrangements. Blood 67:849-858, 1986.
11. Mondello C. Giorgi R, Nuzzo F: Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat Res 139:67-70, 1983.
12. Barbi G, Steinbach P. Vogel W: Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sites. Hum Genet 68:290-294, 1984.
13. Yunis JJ, Soreng AL, Bowe AE: Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1:59-69, 1987.
14. Yunis JJ: Fragile sites, mutagenes and genomic rearrangements in cancer. In Woodhead AD, Bender MA, Leonard RC: "Phenotypic Variations in Populations." New York: Plenum Press. 1988. pp 11-12.
15. Yunis JJ, Hofman WR: Nuclear enzymes, fragile sites, and cancer. Biol Sci 44:37-44, 1989.
16. Sutherland GR, Baker E: Effects of nucleotides on expression of the folate sensitive fragile sites. Am J Hum Genet 23:409-417, 1986.
17. Dipelma J: Chemotherapy of protozoon infections. I. Malaria. In Dipelma J: "Drills Pharmacology in Medicine.: 4th Ed. New York: McGraw-Hill, 1971, pp 1770-1789.
18. Meyers HF, Jawetz E, Goldfien A: "Review of Medical Pharmacology." 4th Ed. Los Altos, CA, 1974.
19. Webster TL: Drugs used in the chemotherapy of protozoal infections. In Gilman AG, Murad F: "The Pharmacological Basis of Therapeutics." 8th Ed. New York: Macmillan, pp 1035-1037.
20. Calva-Mercado MP, Maunory C. Rethore MO. Lejeune J: Fragilite de L'X et inhibition de la dihydrofolate reductase. Comparison des effects de deux antibioliques: Trimethoprime et pyrimethamine. Ann Genet 26:147-149, 1983.
21. Egeli U. Erdoǧan G: The clastogenic effect of pyrimethamine (daraprim) on human chromosomes in lymphocyte cultures. Cell Biol Toxicol 7:347-356, 1991.
22. Ono Y, Norimatsu M, Yashimura H: Induction of chromosome aberrations by pyrimethamine in cultured Chinese hamster (ChI) cells. Mutat Res 323:197-291, 1994.
23. Benn PA, Perle MA: Chromosomal staining and banding techniques. In Rooney DE, Czepulkowski BH: "Human Cytogenetics: A Practical Approach." Oxford: IRL Press, 1986, p 64.
24. Human Gene Mapping 8: Eighth International Workshop on Human Gene Mapping, Helsinki Conference (1985): Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. Cytogenet Cell Genet 40:490-535, 1986.
25. Human Gene Mapping 9: Ninth International Workshop on Human Gene Mapping. Paris conference (1987): Report of the Committee on Cytogenetic Markers. Cytogenet Cell Genet 46:316-343, 1987.
26. Harden DG, Klinger HP (eds): ISCN: An International System for Human Cytogenetic Nomenclature: Published in collaboration with Cytogenet Cell Genet (Basel: S. Karger. 1985); also in Birth Defects: Original Article Series, Vol. 31, No. 1 (New York: March of Dimes Birth Defects Foundation, 1985).
27. Harden DG, Klinger HP (eds): ISCN: An International System for Human Cytogenetic Nomenclature: Published in collaboration with Cytogenet Cell Genet (Basel: S. Karger. 1985); also in Birth Defects: Original Article Series, Vol. 31, No. 1 (New York: March of Dimes Birth Defects Foundation, 1985).
28. Waxman S, Herbert V: Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow. N Eng J Med 280:1316-1319, 1969.
29. Dyke VK: "Antimalarial Durgs." New York: Little, Brown, 1982.
30. Goulian M, Bleile B, Tsent BY: Methotrexate induced misincorporation of uracil into DNA. Proc Natl Acad Sci USA 77:1956-1969, 1980.
31. Yunis JJ. Soreng AL: Constitutive fragile sites and cancer. Science 226:1199-1204, 1984.
32. Krumdieck CL, Howard-Peebles PN: On the nature of folic acid sensitive fragile sites in human chromosomes: An hypothesis. Am J Genet 16:23-28, 1983.
33. Zhou X, Reidy JR, Chen ATL: Chromosome fragility in folic acid-deficient medium. Am J Hum Genet 34:153A, 1982.
34. Rudduck C, Franzen G: A new heritable fragile site on human chromosome 3. Hereditas 98:297-299, 1983.
35. Liu C, Whang G, Li P: The expression frequency of common fragile sites and genetic susceptibility to lung cancers. Cancer Genet Cytogenet 42:107-114, 1989.
36. Egeli Ü, Karadaǧ M, Tunca B. Özyardímcí N: The expression of common fragile sites and genetic predisposition to squamous cell lung cancers. Cancer Genet Cytogenet 20:1-6, 1997.
37. Thillet J, Absil J, Stone SR, Pictet R: Site directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim. J Biol Chem 263:12500-12508, 1988.
38. Jackson RC: Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol Ther 25:61-82, 1984.